Transcode Therapeutics (RNAZ) Other financing activities (2022)

Transcode Therapeutics (RNAZ) has reported Other financing activities for 1 consecutive years, with $5989.0 the latest figure, recorded in Q1 2022.

• For the quarter ending Q1 2022, Other financing activities changed N/A year-over-year to $5989.0; the trailing twelve-month figure through Dec 2022 stood at $5989.0 (changed N/A YoY), and the FY2022 full-year result was $5989.0, down 99.98% from the prior year.
• Other financing activities steadied at $5989.0 in Q1 2022 per RNAZ's latest filing.
• Across five years, Other financing activities topped out at $5989.0 in Q1 2022 and bottomed at $5989.0 in Q1 2022.